Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients

Obesity is a known factor increasing the risk of developing breast cancer and reducing disease free survival. In addition to these well-documented effects, recent studies have shown that obesity is also affecting response to chemotherapy. Among the multiple dysregulations associated with obesity, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gourgue, Florian, Derouane, Françoise, van Marcke, Cedric, Villar, Elodie, Dano, Helene, Desmet, Lieven, Bouzin, Caroline, Duhoux, Francois P., Cani, Patrice D., Jordan, Bénédicte F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110990/
https://www.ncbi.nlm.nih.gov/pubmed/33972642
http://dx.doi.org/10.1038/s41598-021-89385-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110990/
https://www.ncbi.nlm.nih.gov/pubmed/33972642
http://dx.doi.org/10.1038/s41598-021-89385-z

Ejemplares similares